Document 2379 DOCN M94A2379 TI Activated CD8+ lymphocytes in HIV infection. DT 9412 AU De Martinis M; D'Ostilio A; Ginaldi L; Profeta FV; Quaglino D; Clinica Medica University of L'Aquila, Italy. SO Int Conf AIDS. 1994 Aug 7-12;10(1):318 (abstract no. PC0203). Unique Identifier : AIDSLINE ICA10/94370196 AB There are evidence that HIV disease progression is associated with elevated numbers of CD8+ cells that bear the phenotypic surface markers of activated cells (AIDS 1992; 6:793, Clin. Exp. Immunol. 1992; 90:376). This activation of the Immune System may play a role in maintaining an adequate response to lessen the progression of infection. 94 seropositive drug addicts were stratified into four groups based on clinical data: 10 Asymptomatic, 26 LAS, 33 ARC and 25 AIDS. Lymphocyte subsets and the expression of HLA-DR on CD8+ cells from peripheral blood samples were examined by dual-color flow-cytometry using standardized lysed blood method. As control groups were enrolled 22 seronegative drug addicts and 22 healthy subjects. CD8+HLA-DR+ lymphocytes were significantly increased in the HIV-1+ group respect to control groups: mean values HIV + 6.38 + 4.6, HIV-drug addicts 1.13 + 1.7 and healthy 1.0 + 0.7 p < 0.001). The proportion of CD8+HLA-DR+ cells increased progressively with each more advanced HIV clinical stage (from 6% in Asymptomatics to 8.6% in AIDS). There is a significant inverse correlation between CD8+HLA-DR and CD4+ cell counts in the Asymptomatic, LAS and ARC group, while the correlation between the levels of lymphocyte subsets seem to become direct in AIDS patients. Activated CD8+ cells may represent a specific immune response to the virus, contributing to the maintenance of asymptomatic state as long as possible. The progressive damage of the Immune System can explain why CD8+HLA-DR+ cells decrease at the end of the natural history of the disease, when infection overcome. DE Acquired Immunodeficiency Syndrome/IMMUNOLOGY Antigens, CD8/*ANALYSIS AIDS-Related Complex/IMMUNOLOGY Flow Cytometry Human HIV Infections/*IMMUNOLOGY *HIV-1 HLA-DR Antigens/ANALYSIS Leukocyte Count *T-Lymphocyte Subsets MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).